Back to Search
Start Over
396OA multi-center, randomized, double-blind, parallel, two-group phase III trial on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in first-line treatment of non-squamous non-small cell lung cancer.
- Source :
-
Annals of Oncology . 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. - Publication Year :
- 2018
- Subjects :
- *NON-small-cell lung carcinoma
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 29
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 133479197
- Full Text :
- https://doi.org/10.1093/annonc/mdy442